MarketPulse

chikungunya vaccine

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bavarian Nordic's Chikungunya Vaccine Wins Swiss Approval, Expanding Global Market Access

Bavarian Nordic's chikungunya vaccine VIMKUNYA wins Swiss regulatory approval, marking the fourth major authorization in 2025 following FDA, EMA, and MHRA clearances.
BVNRYregulatory approvalinfectious disease
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bavarian Nordic Wins Swiss Approval for Chikungunya Vaccine VIMKUNYA

Bavarian Nordic secures Swiss regulatory approval for chikungunya vaccine VIMKUNYA, marking fourth major market clearance in 2025 following FDA, EMA, and MHRA approvals.
BVNRYregulatory milestonevaccine development